Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals, Inc. (RYTM) Insider Trading
Directors, officers and holders of more than 10% of RYTM report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 460 transactions on file: 0 with code P, 20 with code S and 30 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Meeker David P | President and CEO | S Sale | 2,300 | $105.19 | $241,937 |
| Sep 14, 2026 | Meeker David P | President and CEO | S Sale | 6,439 | $101.75 | $655,145 |
| Sep 14, 2026 | Meeker David P | President and CEO | S Sale | 8,698 | $103.43 | $899,634 |
| Sep 14, 2026 | Meeker David P | President and CEO | S Sale | 30,746 | $102.35 | $3,146,761 |
| Sep 14, 2026 | Meeker David P | President and CEO | M Exercise | 50,000 | $6.05 | $302,500 |
| Sep 14, 2026 | Meeker David P | President and CEO | S Sale | 1,817 | $104.55 | $189,965 |
| Sep 14, 2026 | Meeker David P | President and CEO | M Exercise | 50,000 | Not measured | Not measured |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | S Sale | 28,188 | $106.20 | $2,993,647 |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | M Exercise | 57,187 | $25.79 | $1,474,853 |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | M Exercise | 57,187 | Not measured | Not measured |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | S Sale | 23,072 | $104.59 | $2,413,034 |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | S Sale | 11,514 | $105.37 | $1,213,232 |
| Aug 17, 2026 | Joshi Manher | Chief Medical Officer | A Award | 50,000 | Not measured | Not measured |
| Aug 17, 2026 | Joshi Manher | Chief Medical Officer | A Award | 25,000 | Not measured | Not measured |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | S Sale | 3,400 | $118.28 | $402,167 |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | M Exercise | 35,000 | Not measured | Not measured |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | S Sale | 2,007 | $116.11 | $233,031 |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | S Sale | 800 | $119.17 | $95,335 |
| Aug 13, 2026 | Shulman Joseph | Chief Technical Officer | M Exercise | 2,024 | Not measured | Not measured |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | S Sale | 75,834 | $117.38 | $8,901,531 |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | S Sale | 1,556 | $117.08 | $182,170 |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | M Exercise | 21,601 | Not measured | Not measured |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | M Exercise | 21,601 | $6.80 | $146,887 |
| Aug 13, 2026 | Shulman Joseph | Chief Technical Officer | M Exercise | 2,024 | $6.80 | $13,763 |
| Aug 13, 2026 | Shulman Joseph | Chief Technical Officer | S Sale | 5,079 | $119.75 | $608,210 |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | M Exercise | 35,000 | $24.29 | $850,150 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 18,208 | $116.49 | $2,121,125 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | M Exercise | 46,625 | Not measured | Not measured |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | M Exercise | 46,625 | $6.80 | $317,050 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 2,300 | $111.80 | $257,138 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 1,000 | $112.86 | $112,856 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 3,605 | $114.70 | $413,477 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 14,568 | $115.43 | $1,681,541 |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | S Sale | 17,319 | $117.47 | $2,034,439 |
| Jul 1, 2026 | Garfield Alastair | Chief Scientific Officer | M Exercise | 4,445 | Not measured | Not measured |
| Jul 1, 2026 | Garfield Alastair | Chief Scientific Officer | F Tax Payment | 2,150 | $110.41 | $237,382 |
| Jul 1, 2026 | Garfield Alastair | Chief Scientific Officer | M Exercise | 4,445 | Not measured | Not measured |
| Jun 24, 2026 | GOOD JENNIFER L | Director | A Award | 3,691 | Not measured | Not measured |
| Jun 24, 2026 | Arbuckle Stuart A | Director | A Award | 3,691 | Not measured | Not measured |
| Jun 24, 2026 | TETRAULT LYNN A. | Director | A Award | 2,324 | Not measured | Not measured |
| Jun 24, 2026 | TETRAULT LYNN A. | Director | A Award | 3,691 | Not measured | Not measured |
| Jun 24, 2026 | GOOD JENNIFER L | Director | A Award | 2,324 | Not measured | Not measured |
| Jun 24, 2026 | MCGIRR DAVID W J | Director | A Award | 3,691 | Not measured | Not measured |
| Jun 24, 2026 | JEAN CHRISTOPHE | Director | A Award | 2,324 | Not measured | Not measured |
| Jun 24, 2026 | JEAN CHRISTOPHE | Director | A Award | 3,691 | Not measured | Not measured |
| Jun 24, 2026 | MCGIRR DAVID W J | Director | A Award | 2,324 | Not measured | Not measured |
| Jun 24, 2026 | Arbuckle Stuart A | Director | A Award | 2,324 | Not measured | Not measured |
| Jun 23, 2026 | JEAN CHRISTOPHE | Director | M Exercise | 4,712 | Not measured | Not measured |
| Jun 23, 2026 | MCGIRR DAVID W J | Director | M Exercise | 4,712 | Not measured | Not measured |
| Jun 23, 2026 | GOOD JENNIFER L | Director | M Exercise | 4,712 | Not measured | Not measured |
The full Form 4 history is on the RYTM company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.